T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Enrolling by invitation · NCT06481956 · Registry updated 2024-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| T-DM1 Combined With CDK4/6 Inhibitor Ribociclib | HER2-positive Advanced Breast Cancer | Enrolling by invitation | Phase 2 | 2024-07-01 | NCT06481956 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zheng Yabing | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |